High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
Sign Up to like & getrecommendations! Published in 2023 at "Blood"
DOI: 10.1182/blood.2023019634
Abstract: Complex karyotypes have been associated with inferior outcomes in chronic lymphocytic leukemia (CLL) treated with chemoimmunotherapy (CIT) while their prognostic impact in the context of venetoclax-based treatments is still debated. In this prospective analysis on… read more here.
Keywords: cll treated; venetoclax based; complexity; complex karyotypes ... See more keywords